Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027524> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q66027524 description "assaig clínic" @default.
- Q66027524 description "clinical trial" @default.
- Q66027524 description "clinical trial" @default.
- Q66027524 description "clinical trial" @default.
- Q66027524 description "clinical trial" @default.
- Q66027524 description "ensaio clínico" @default.
- Q66027524 description "ensayo clínico" @default.
- Q66027524 description "ensayu clínicu" @default.
- Q66027524 description "essai clinique" @default.
- Q66027524 description "klinisch onderzoek" @default.
- Q66027524 description "клінічне випробування" @default.
- Q66027524 name "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer." @default.
- Q66027524 name "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer." @default.
- Q66027524 type Item @default.
- Q66027524 label "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer." @default.
- Q66027524 label "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer." @default.
- Q66027524 prefLabel "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer." @default.
- Q66027524 prefLabel "Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non Small Cell Lung Cancer." @default.
- Q66027524 P1132 Q66027524-E1E019EF-024A-42BB-9F4F-BA47B575651C @default.
- Q66027524 P1476 Q66027524-6757B218-242A-4C0C-B879-2D22AA67F1D2 @default.
- Q66027524 P17 Q66027524-86C8B916-A41C-41B5-A55D-A354ADD7934A @default.
- Q66027524 P17 Q66027524-B6AF3F8C-673D-4FDE-B9DB-E173A36674C8 @default.
- Q66027524 P2899 Q66027524-99483F9B-621E-4B7F-BE1B-167CB697D014 @default.
- Q66027524 P3098 Q66027524-E6F80991-AD41-4DCC-A867-CFE585C46D02 @default.
- Q66027524 P31 Q66027524-FAFA117A-44BF-4641-85ED-88865C985418 @default.
- Q66027524 P580 Q66027524-D0019A60-54D1-4D86-BB57-95468BC55E41 @default.
- Q66027524 P582 Q66027524-70B31EAE-442B-4603-90F8-B86DDEC3F91C @default.
- Q66027524 P6099 Q66027524-10986E87-7E0C-444D-BAD6-8FEB446DCB1D @default.
- Q66027524 P8363 Q66027524-25DCEDCE-9799-4A23-ADDF-D32695A8249F @default.
- Q66027524 P1132 "+112" @default.
- Q66027524 P1476 "Phase II Open-label Study to Investigate the Efficacy and Safety of PTK787/ZK 222584 Orally Administered Once Daily or Twice Daily at 1250 mg as Second-line Monotherapy in Patients With Stage IIIB or Stage IV Non-small-cell Lung Cancer (NSCLC)" @default.
- Q66027524 P17 Q142 @default.
- Q66027524 P17 Q183 @default.
- Q66027524 P2899 "+18" @default.
- Q66027524 P3098 "NCT00160043" @default.
- Q66027524 P31 Q30612 @default.
- Q66027524 P580 "2005-03-01T00:00:00Z" @default.
- Q66027524 P582 "2007-08-01T00:00:00Z" @default.
- Q66027524 P6099 Q42824440 @default.
- Q66027524 P8363 Q78089383 @default.